Mucoepidermoid carcinoma medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 4: Line 4:


==Overview==
==Overview==
There is no medical treatment for mucoepidermoid carcinoma. Radiotherapy can be neoadjuvant treatment in some lesions (dependent on the tumor stage and size).
There is no medical treatment for mucoepidermoid carcinoma. [[Radiotherapy]] can be neoadjuvant treatment in some lesions (dependent on the tumor stage and size).
==Medical Therapy==
==Medical Therapy==
There is no medical treatment for mucoepidermoid carcinoma, However chemotherapy can be used in order to shrink down the tumor. Chemptherapy can be the option for palliative care. Following agents can be used: Radiotherapy can be neoadjuvant treatment in some lesions (dependent on the tumor stage and size).<ref name="pmid6731349">{{cite journal |vauthors=Evans HL |title=Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading |journal=Am. J. Clin. Pathol. |volume=81 |issue=6 |pages=696–701 |year=1984 |pmid=6731349 |doi= |url=}}</ref><ref name="pmid6731349">{{cite journal |vauthors=Evans HL |title=Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading |journal=Am. J. Clin. Pathol. |volume=81 |issue=6 |pages=696–701 |year=1984 |pmid=6731349 |doi= |url=}}</ref>
There is no medical treatment for mucoepidermoid carcinoma, However [[chemotherapy]] can be used in order to shrink down the tumor. [[Chemotherapy]] can be the option for palliative care. Following agents can be used: [[Radiotherapy]] can be neoadjuvant treatment in some lesions (dependent on the tumor stage and size).<ref name="pmid6731349">{{cite journal |vauthors=Evans HL |title=Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading |journal=Am. J. Clin. Pathol. |volume=81 |issue=6 |pages=696–701 |year=1984 |pmid=6731349 |doi= |url=}}</ref><ref name="pmid6731349">{{cite journal |vauthors=Evans HL |title=Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading |journal=Am. J. Clin. Pathol. |volume=81 |issue=6 |pages=696–701 |year=1984 |pmid=6731349 |doi= |url=}}</ref>


** Doxorubicin  
** [[Doxorubicin]]
** Mitoxantrone  
** [[Mitoxantrone]]
** Vinorelbine,  
** [[Vinorelbine|Vinorelbine,]]
** A new form of 5-fluorouracil called fluoropyrimidine  
** A new form of [[5-fluorouracil]] called fluoropyrimidine  
* Newer combinations with antimicrotubule agents such as cisplatin has shown some efficacy in malignant tumors.  
* Newer combinations with [[Antimicrotubule agent|antimicrotubule agents]] such as [[cisplatin]] has shown some efficacy in malignant tumors.  
* Paclitaxel has demonstrated moderate activity against mucoepidermoid tumors and adenocarcinomas but no effect adenoid cystic carcinoma.<ref name="pmid19052760">{{cite journal |vauthors=Stenner M, Klussmann JP |title=Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved |journal=Eur Arch Otorhinolaryngol |volume=266 |issue=3 |pages=333–41 |date=March 2009 |pmid=19052760 |doi=10.1007/s00405-008-0882-7 |url=}}</ref>
* [[Paclitaxel]] has demonstrated moderate activity against mucoepidermoid tumors and [[adenocarcinomas]] but no effect adenoid cystic carcinoma.<ref name="pmid19052760">{{cite journal |vauthors=Stenner M, Klussmann JP |title=Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved |journal=Eur Arch Otorhinolaryngol |volume=266 |issue=3 |pages=333–41 |date=March 2009 |pmid=19052760 |doi=10.1007/s00405-008-0882-7 |url=}}</ref>


*Various biological agents under investigation are:  
*Various biological agents under investigation are:  
** Trastuzumab
** [[Trastuzumab]]
** Imatinib
** [[Imatinib]]
** Cetuximab  
** [[Cetuximab]]


===Radiotherapy===
===Radiotherapy===
Radiotherpy can be used alone in non resecatable tumors as well as adjuvant therapy after surgery and chemotherapy.  
[[Radiotherapy]] can be used alone in non resecatable tumors as well as adjuvant therapy after surgery and [[chemotherapy]]. Various techniques using radiotherapy has demonstrated significant efficiacy in treatment of salivary gland tumors:  
Various techniques using radiotherapy has demonsttrated significant efficiacy in treatment of salivary gland tumors:  
** Gamma-knife [[stereotactic radiosurgery]]
** Gamma-knife stereotactic radiosurgery  
** [[Brachytherapy]]
** Brachytherapy  
** [[Iodine-125]]
** Iodine-125
** [[Proton]] based radiation
** Proton based radiation
** [[Neutron]] therapy<ref name="pmid30630270">{{cite journal |vauthors=Park G, Lee SW |title=Postoperative radiotherapy for mucoepidermoid carcinoma of the major salivary glands: long-term results of a single-institution experience |journal=Radiat Oncol J |volume=36 |issue=4 |pages=317–324 |date=December 2018 |pmid=30630270 |doi=10.3857/roj.2018.00409 |url=}}</ref>
** Neutron therapy<ref name="pmid30630270">{{cite journal |vauthors=Park G, Lee SW |title=Postoperative radiotherapy for mucoepidermoid carcinoma of the major salivary glands: long-term results of a single-institution experience |journal=Radiat Oncol J |volume=36 |issue=4 |pages=317–324 |date=December 2018 |pmid=30630270 |doi=10.3857/roj.2018.00409 |url=}}</ref>


==References==
==References==
Line 34: Line 33:
{{WH}}
{{WH}}
{{WS}}
{{WS}}


[[Category:Disease]]
[[Category:Disease]]

Latest revision as of 19:39, 22 January 2019

Mucoepidermoid carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mucoepidermoid Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mucoepidermoid carcinoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mucoepidermoid carcinoma medical therapy

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mucoepidermoid carcinoma medical therapy

CDC on Mucoepidermoid carcinoma medical therapy

Mucoepidermoid carcinoma medical therapy in the news

Blogs on Mucoepidermoid carcinoma medical therapy

Directions to Hospitals Treating Mucoepidermoid carcinoma

Risk calculators and risk factors for Mucoepidermoid carcinoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2] , Maria Fernanda Villarreal, M.D. [3]

Overview

There is no medical treatment for mucoepidermoid carcinoma. Radiotherapy can be neoadjuvant treatment in some lesions (dependent on the tumor stage and size).

Medical Therapy

There is no medical treatment for mucoepidermoid carcinoma, However chemotherapy can be used in order to shrink down the tumor. Chemotherapy can be the option for palliative care. Following agents can be used: Radiotherapy can be neoadjuvant treatment in some lesions (dependent on the tumor stage and size).[1][1]

Radiotherapy

Radiotherapy can be used alone in non resecatable tumors as well as adjuvant therapy after surgery and chemotherapy. Various techniques using radiotherapy has demonstrated significant efficiacy in treatment of salivary gland tumors:

References

  1. 1.0 1.1 Evans HL (1984). "Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading". Am. J. Clin. Pathol. 81 (6): 696–701. PMID 6731349.
  2. Stenner M, Klussmann JP (March 2009). "Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved". Eur Arch Otorhinolaryngol. 266 (3): 333–41. doi:10.1007/s00405-008-0882-7. PMID 19052760.
  3. Park G, Lee SW (December 2018). "Postoperative radiotherapy for mucoepidermoid carcinoma of the major salivary glands: long-term results of a single-institution experience". Radiat Oncol J. 36 (4): 317–324. doi:10.3857/roj.2018.00409. PMID 30630270.

Template:WH Template:WS